Mounjaro explained as 'All About That Bass' singer Meghan Trainor admits to using it amid major weight loss transformation.

One endocrinologist told the Hollywood Reporter that her patients have started asking about microdosing Ozempic as way to ...

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro ... and also delay emptying of food from the stomach. This causes a feeling of fullness even ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

US pharma giant Eli Lilly's obesity management drug Mounjaro has now been launched in India. Interestingly, compared to the US, the price of Mounjaro in India will be one-fifth. Apart from obesity, ...

In a single-dose vial presentation Eli Lilly, a pharmaceutical firm has announced the launch of Mounjaro, following the authorization from the Central Drugs Standard Control Organization (CDSCO). The ...

India’s wait is over. The popular anti-obesity drug Mounjaro is finally here. The development comes after Eli Lilly received approval from India’s Central Drugs Standard Control Organisation (CDSCO).

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling with obesity and diabetes. Priced between 3,500 and 4,375 rupees per vial, ...

Mounjaro injectable prescription medication designed to aid weight loss and manage Type 2 diabetes. It belongs to a new class of medications that act as both glucose-dependent insulinotropic ...

"The benefits of Mounjaro include effective blood sugar control and substantial weight loss. However, users may experience side effects such as nausea, diarrhea, decreased appetite, vomiting, ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...